Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001193125-25-316180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMTI | 2025-12-11 | 2025-12-09 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $51.40 | +34.4K | 132.7K | +35% | +$1.77M |
| DMTI | 2025-12-11 | 2025-12-09 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $67.08 | -34.4K | 98.4K | -26% | -$2.31M |
| DMTI | 2025-12-11 | 2025-12-09 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -34.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-09 | M | A | 10,615 | $64.60 | 108,992 | I By a trust | — | — | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 2 | Common | Class A Common Stock | 2025-12-09 | M | A | 23,752 | $45.50 | 132,744 | I By a trust | — | — | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 3 | Common | Class A Common Stock | 2025-12-09 | S | D | 28,168 | $66.99 | 104,576 | I By a trust | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 4 | Common | Class A Common Stock | 2025-12-09 | S | D | 6,199 | $67.51 | 98,377 | I By a trust | — | — | (F3) The shares were sold in multiple transactions at prices ranging from $67.39 to $67.60, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-09 | M | D | 10,615 | $0.00 | 0 | I By a trust | $45.50 · — to 2026-12-15 | 10,615 Class A Common Stock | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F5) This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-09 | M | D | 23,752 | $0.00 | 0 | I By a trust | $64.60 · — to 2025-12-17 | 23,752 Class A Common Stock | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F6) This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares. |